Literature DB >> 8314490

Problems in diagnosing viral hepatitis.

F Bonino1, G Colloredo Mels, G Bellati, G Ideo, F Oliveri, P Colombatto, M R Brunetto.   

Abstract

The most reliable method of making a specific aetiological diagnosis of chronic viral hepatitis would be to identify virus specific cytotoxic T lymphocytes responsible for the killing of virus infected hepatocytes in each patient's liver. Unfortunately, this can not be proposed for routine diagnosis and surrogate tests are required. The detection of virus markers, and even of the virus itself, does not imply that liver damage is caused by virus infection. Indirect markers of the host's antiviral immunoresponse have to be used to confirm more specifically the diagnosis of viral hepatitis. IgM antibodies against viral antigens implicated in the elimination of the virus seem to be suitable alternative candidates. Significant changes in the serum values of viraemia and aminotransferases occur within a few days, while a significant variation in liver histology takes much longer. Only the kinetics of the highly variable parameters can be used for an appropriate study of the relationship between viraemia, antiviral immunoresponse, and liver cell necrosis. Quantitative and dynamic analyses of hepatitis virus markers seem the most suitable and reliable methods of monitoring the patients eligible for antiviral treatment and identifying the most appropriate time to start this.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314490      PMCID: PMC1374001          DOI: 10.1136/gut.34.2_suppl.s36

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

Review 1.  Polymerase chain reaction. A new tool for the study of viral infections in hepatology.

Authors:  C Bréchot
Journal:  J Hepatol       Date:  1990-07       Impact factor: 25.083

Review 2.  The ligase chain reaction in a PCR world.

Authors:  F Barany
Journal:  PCR Methods Appl       Date:  1991-08

Review 3.  Liver transplantation in carriers of the HBsAg.

Authors:  M Rizzetto; S Recchia; M Salizzoni
Journal:  J Hepatol       Date:  1991-07       Impact factor: 25.083

4.  The importance of hepatitis B viral DNA in serum and liver.

Authors:  F Bonino
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

5.  IgM anti-HBc in anti-HBe positive chronic type B hepatitis with acute exacerbations.

Authors:  K Koike; S Iino; K Kurai; K Mitamura; Y Endo; H Oka
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

6.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

7.  Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.

Authors:  N C Tassopoulos; M H Sjogren; J R Ticehurst; R E Engle; A Roumeliotou-Karayannis; J L Gerin; R H Purcell; G Papaevangelou
Journal:  Liver       Date:  1986-10

8.  Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

Authors:  W H Gerlich; A Uy; F Lambrecht; R Thomssen
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

9.  Genetic disease detection and DNA amplification using cloned thermostable ligase.

Authors:  F Barany
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

Authors:  F Bonino; B Hoyer; J Nelson; R Engle; G Verme; J Gerin
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  1 in total

Review 1.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.